Insights Into Imaging

Journal Title：Insights Into Imaging

Insights into Imaging (I³) is a peer-reviewed open access journal published under the brand SpringerOpen. All content published in the journal is freely available online to anyone, anywhere!

I³ continuously updates scientific knowledge and progress in best-practice standards in radiology through the publication of original articles and state-of-the-art reviews and opinions, along with recommendations and statements from the leading radiological societies in Europe.

Founded by the European Society of Radiology (ESR), I³ creates a platform for educational material, guidelines and recommendations, and a forum for topics of controversy.

A balanced combination of review articles, original papers, short communications from European radiological congresses and information on society matters makes I³ an indispensable source for current information in this field.

I³ is owned by the ESR, however authors retain copyright to their article according to the Creative Commons Attribution License (see Copyright and License Agreement). All articles can be read, redistributed and reused for free, as long as the author of the original work is cited properly.

The open access fees (article-processing charges) for this journal are kindly sponsored by ESR for all Members.

The journal went open access in 2012, which means that all articles published since then are freely available online.

Insights into Imaging (I³) 是一份经过同行评审的开放获取期刊，以 SpringerOpen 品牌出版。发表在期刊上的所有内容都可以在线免费提供给任何人、任何地方！

I³ 通过发表原创文章和最先进的评论和意见，以及欧洲主要放射学会的建议和声明，不断更新科学知识和放射学最佳实践标准的进展。

由欧洲放射学会 (ESR) 创立，I³ 创建了一个教育材料、指南和建议的平台，以及一个争议话题的论坛。

评论文章、原始论文、欧洲放射学大会的简短交流和社会事务信息的平衡组合使 I³ 成为该领域当前信息不可或缺的来源。

I³ 归 ESR 所有，但作者根据知识共享署名许可保留其文章的版权（请参阅版权和许可协议）。只要正确引用原著的作者，所有文章都可以免费阅读、重新分发和重复使用。

本期刊的开放获取费用（文章处理费用）由 ESR 赞助所有会员。

该期刊于 2012 年开放获取，这意味着此后发表的所有文章均可在线免费获取。

Insights Into Imaging创刊于2010年，由SPRINGER出版商出版，收稿方向涵盖Medicine - Radiology, Nuclear Medicine and Imaging全领域，此刊是该细分领域中属于非常不错的SCI期刊，在行业细分领域中学术影响力较大，专业度认可很高，所以对原创文章要求创新性较高，如果您的文章质量很高，可以尝试。平均审稿速度13 Weeks，影响因子指数3.579，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。